These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 3711553

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Long-term efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol.
    Weinstein SF, Andrews CP, Shah SR, Chylack LT, Tankelevich A, Ding Y, Tantry SK.
    Allergy Asthma Proc; 2014; 35(4):323-31. PubMed ID: 24992552
    [Abstract] [Full Text] [Related]

  • 46. An open comparison of dosage frequencies of beclomethasone dipropionate in seasonal allergic rhinitis.
    Munch E, Gomez G, Harris C, Lack RP, Edwards VA, O'Connor P, Snowden DV, Mygind N.
    Clin Allergy; 1981 May; 11(3):303-9. PubMed ID: 7249345
    [Abstract] [Full Text] [Related]

  • 47. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation.
    Baroody FM, Rouadi P, Driscoll PV, Bochner BS, Naclerio RM.
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):899-906. PubMed ID: 9517609
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Comparative trial of flunisolide and beclomethasone dipropionate nasal sprays in patients with seasonal allergic rhinitis.
    Sipilä P, Sorri M, Ojala K, Palva A.
    Allergy; 1983 Jul; 38(5):303-7. PubMed ID: 6137165
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Efficacy and safety of beclomethasone dipropionate nasal aerosol in children with perennial allergic rhinitis.
    Berger WE, Jacobs RL, Amar NJ, Tantry SK, Li J, Small CJ.
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):130-6. PubMed ID: 26115578
    [Abstract] [Full Text] [Related]

  • 54. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R.
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Multicentric study of beclomethasone dipropionate nasal aerosol in adults with seasonal allergic rhinitis.
    Siegel SC, Katz RM, Rachelefsky GS, Geller BD, Montag LL, Brandon ML, Cannon SJ.
    J Allergy Clin Immunol; 1982 Apr; 69(4):345-53. PubMed ID: 7040528
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.